Displaying items 49-60 of 203
» View courant.com items only
< Previous
•
1
2
3
4
5
6
7
8
9
10
11-17
•
Next >
-
The day ahead in business April 24
Reports: MBA mortgage index for week ended April 20, 6 a.m.; Durable goods orders for March, 7:30 a.m.; Crude inventories for week ended April 20, 9:30 a.m. Local earnings: Boeing Co., First Midwest Bancorp Inc., Horace Mann Educators Corp., Morningstar...
Tags: Credit Suisse Group, Stericycle Incorporated, Zynga Inc., Lilly Eli & Co, Ford Motor Co.
-
GSK opts to sell off Lucozade and Ribena drink brands
ReutersLONDON, April 24 (Reuters) - GlaxoSmithKline has decided to sell its popular soft drink brands Lucozade and Ribena in a disposal that could bring in more than 1 billion pounds ($1.5 billion). The move was announced on Wednesday alongside weak first-...Tags: New Products
-
GSK to partner with venture capital firm for drug discovery
ReutersApril 22 (Reuters) - GlaxoSmithKline said on Monday it will partner with venture capitalists Avalon Ventures in a deal worth up to $495 million to fund as many as 10 drug-discovery startup companies over the next three years. GSK will provide financing...Tags: Startups, Avalon Ventures Limited
-
Fight tobacco marketing, boost vaccinations to curb cancer, says report
ReutersLONDON (Reuters) - Fighting the tobacco industry's tactics in the world's poorest countries and ensuring the best vaccines get to those most in need are key to cutting the number of cancer deaths worldwide, according to a report by specialists in the...Tags: Chemical Industry, Lung Cancer, Medical Research, Tobacco Products, Disease Prevention
-
Big pharma: Few new antibiotics in the works
Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers saw an opportunity and raced to develop new medicines. Today, as the world confronts the crisis of antibiotic resistance, the industry...
Tags: Staphylococcal Infection , Food and Drug Administration, Tuberculosis, Research, Merck & Company Incorporated
-
Do soaps with triclosan do more harm than good?
If co-workers and family members are coming down with infections this winter, you may be tempted to turn to an anti-bacterial soap for protection. But some scientists are increasingly concerned that a common anti-bacterial ingredient called triclosan...
Tags: Gingivitis, Health and Safety at Work, Chemical Industry, Science, Conservation
-
State AG sues maker of diabetes drugs for false advertising
Maryland Attorney General Douglas F. Gansler said Wednesday he has filed a lawsuit against GlaxoSmithKline, LLC for falsely saying three of its diabetes drugs were better than others on the market. The company also withheld data that showed the drugs...
Tags: Douglas F. Gansler, Chemical Industry, Diabetes, Litigation, Crime, Law and Justice
-
Amgen pleads guilty, to settle misbranding case for $762 million
Biotech giant Amgen Inc. pleaded guilty to a federal misdemeanor of misbranding its anemia drug Aranesp and has agreed to pay $762 million in fines and penalties. The Thousand Oaks company said it had reached a preliminary settlement of federal criminal...Tags: Food and Drug Administration, Anemia, Lawyers, Crime, Law and Justice, Amgen Inc.
-
Corporations and execs need penalties that hurt
If you're concerned about corporate crime, 2012 looked like a pretty successful year for the good guys. The Thousand Oaks biotech giant Amgen paid $762 million in fines and penalties and pleaded guilty to a federal charge related to illegal marketing of...
Tags: Bank of America Corp., U.S. Securities and Exchange Commission, Schering Plough Corporation, Crime, Law and Justice, Securities
-
Appeals court puts 1st Amendment over public health
The Food, Drug and Cosmetic Act makes it illegal to sell a prescription drug for any purpose other than what's listed on the label. Nevertheless, a divided federal appeals court this week tossed out the conviction of a former drug sales rep who was...Tags: Chemical Industry, Food and Drug Administration, Pfizer Inc., U.S. Congress, Prescription Drugs
-
Human Genome to lay off 97 workers
Human Genome Sciences Inc., which was acquired for $3.6 billion by London-based GlaxoSmithKline Plc in August, intends to lay off 97 employees in mid-December, and an additional but unspecified number of cuts are planned for next year, the company...Tags: Unemployment, Labor Legislation, Human Genome Sciences Inc., Career and Workplace, Layoffs and Downsizing
-
EU advises all girls need cervical cancer vaccines
ReutersLONDON (Reuters) - All girls in Europe should be immunized against the human papillomavirus (HPV) that causes cervical cancer and current vaccine coverage rates are far too low, European Union health officials said on Wednesday. In new advice about...Tags: Chemical Industry, Disease Prevention, HPV Vaccine, Merck & Company Incorporated, Drugs and Medicines
Apr 24, 2013
|Story| Chicago Tribune
Apr 24, 2013
|Story| Reuters
Apr 22, 2013
|Story| Reuters
Mar 6, 2013
|Story| Reuters
Mar 19, 2013
|Story| Reuters
Feb 10, 2013
|Story| Chicago Tribune
Feb 20, 2013
|Story| Baltimore Sun
Dec 18, 2012
|Story| Los Angeles Times
Jan 5, 2013
|Column| Los Angeles Times
Dec 7, 2012
|Column| Los Angeles Times
Oct 17, 2012
|Story| Baltimore Sun
Sep 4, 2012
|Story| Reuters
Original site for GlaxoSmithKline PLC topic gallery.
